Reported adverse effects and drug interactions of triazolam (Halcion).
Wynn
Richard L
RL
Department of Oral Craniofacial Biological Sciences, Dental School, University of Maryland, Baltimore, USA.
Bergman
Stewart A
SA
D001569:Benzodiazepines / Q000009:adverse effects* / Q000378:metabolism; D051544:Cytochrome P-450 CYP3A; D065607:Cytochrome P-450 Enzyme Inhibitors; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D004790:Enzyme Induction; D004791:Enzyme Inhibitors; D006801:Humans; D014229:Triazolam / Q000009:adverse effects* / Q000378:metabolism
D065607:Cytochrome P-450 Enzyme Inhibitors; D004791:Enzyme Inhibitors; D001569:Benzodiazepines; D014229:Triazolam; D003577:Cytochrome P-450 Enzyme System; C104464:CYP3A protein, human; D051544:Cytochrome P-450 CYP3A